ABBV-022

N/A

Report date: 2022/01/24 10:09:35

Base Information

Drug NameABBV-022

Drug Alias NameABBV-022

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionInterleukin-22 receptor agonists

TargetsInterleukin-22 receptor

Therapy Area/IndicationsColitis, Ulcerative

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc

China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc

Inactive CompaniesN/A

Active IndicationsColitis, Ulcerative

Inactive IndicationsN/A

Other Information

ATC CodeN/A